sparsentan will reduce the extent or effect of modafinil by impacting hepatic enzyme CYP2C19 metabolism. Use Warning/Observe. Sparsentan (a CYP2C19 inducer) decreases exposure of CYP2C19 substrates and reduces efficacy connected to these substrates. saquinavir will enhance the level or outcome of modafinil by affecting hepatic/intestinal enz